Resultados de la búsqueda 441-450 of 13759 for Raynaud phenomenon
InPACT-neoadjuvant patients are stratified by disease burden as ... disease and factors that may determine disease progression and treatment response.
... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...
A Study to Assess Long-term Symptom Improvement and Recurrence after Operative Management of Popliteal Artery Entrapment Syndrome (PAES). Rochester, Minn ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these ...
... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...
American Diabetes Association. https://diabetes.org/diabetes/neuropathy. Accessed Sept. 7, 2023. All about your A1C. Centers for Disease Control and Prevention.
The goal of this research is to investigate the hypothesis that this presentation represents a spatially limited form of CNS inflammatory demyelinating disease.
Jacksonville, Fla. The purpose of this study is to validate the use of a lymphatic imaging protocol to stage disease severity in patients with lymphedema and ...
A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?